IL6 and colorectal carcinoma: Orally administered B. longum can inhibit the NF-κB signaling pathway in the colons of CRC rats, down-regulate IL-1β and IL-6, and prevent CRC,55 indicating that overactivation of NF-κB leads to the expression of pro-inflammatory cytokines, promoting the occurrence of CRC.